Invitae Corp NVTA:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
27.60quote price arrow down-0.14 (-0.50%)
Volume
144,816
Close
27.74quote price arrow up+1.65 (+6.32%)
Volume
4,003,657
52 week range
15.12 - 61.59

...

Loading . . .
  • Open26.28
  • Day High28.16
  • Day Low26.28
  • Prev Close26.09
  • 52 Week High61.59
  • 52 Week High Date12/14/20
  • 52 Week Low15.12
  • 52 Week Low Date05/15/20

Key Stats

  • Market Cap5.817B
  • Shares Out209.68M
  • 10 Day Average Volume5.53M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change-33.65

KEY STATS

  • Open26.28
  • Day High28.16
  • Day Low26.28
  • Prev Close26.09
  • 52 Week High61.59
  • 52 Week High Date12/14/20
  • 52 Week Low15.12
  • 52 Week Low Date05/15/20
  • Market Cap5.817B
  • Shares Out209.68M
  • 10 Day Average Volume5.53M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change-33.65

RATIOS/PROFITABILITY

  • EPS (TTM)-3.93
  • P/E (TTM)-7.06
  • Fwd P/E (NTM)-10.80
  • EBITDA (MRQ)-594.584M
  • ROE (MRQ)-45.38%
  • Revenue (MRQ)318.97M
  • Gross Margin (MRQ)26.84%
  • Net Margin (MRQ)-192.22%
  • Debt To Equity (MRQ)19.17%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:2204:22
Invitae CEO on the importance of genetic testing for preventative care

Profile

MORE
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer...
Sean George Ph.D.
Chairman
Kenneth Knight
Chief Operating Officer
Shelly Guyer
Chief Financial Officer
Robert Werner
Chief Accounting Officer
Thomas Brida J.D.
General Counsel
Address
1400 16th St
San Francisco, CA
94103-5110
United States

Top Peers

SYMBOLLASTCHG%CHG
DNLI
Denali Therapeutics Inc
53.90+2.20+4.26%
HALO
Halozyme Therapeutics Inc
43.03+1.26+3.02%
TWST
Twist Bioscience Corp
92.68+4.55+5.16%
SRPT
Sarepta Therapeutics Inc
76.05+3.54+4.88%
RARE
Ultragenyx Pharmaceutical Inc
110.88+4.17+3.91%